← Leaderboards
Sheila K West
Johns Hopkins University
$23,441,173
Attributed
$23,441,173
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.6M · FY2005–15$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$23,441,173 · 11
By mechanism
R01$14,090,449 · 6
U10$4,511,629 · 1
U01$3,186,993 · 1
P30$1,367,138 · 1
R03$284,964 · 2
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- John H. Kempen$14,361,889
- Frank R Lin$23,862,308
- Jennifer Ann Schrack$37,433,611
- Yuri Agrawal$7,705,031
- Shameema Sikder$1,013,606
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsClinical ResearchHuman SubjectDesignVision TestsVision DisordersProgramsLongitudinal Human StudyQuestionnairesMonitorCommunitiesSentinelInfectionHuman Therapy EvaluationTrachomaEye Disorder DiagnosisAreaPrevalenceAntibiotic TherapyFundingAzithromycinVisionFollow-UpEpidemiology
Grant awards (43)
Surveillance & Treatment of Community Newcomers & Travelers for Trachoma Control$906,708
U10 · FY2015 · EY · contact PI
Surveillance & Treatment of Community Newcomers & Travelers for Trachoma Control$1,225,633
U10 · FY2014 · EY · contact PI
Surveillance & Treatment of Community Newcomers & Travelers for Trachoma Control$1,322,034
U10 · FY2013 · EY · contact PI
Surveillance & Treatment of Community Newcomers & Travelers for Trachoma Control$978,043
U10 · FY2012 · EY · contact PI
Surveillance & Treatment of Community Newcomers & Travelers for Trachoma Control$79,211
U10 · FY2012 · EY · contact PI
Who drives safely? Visual/cognitive predictors in Elders$489,264
R01 · FY2008 · AG · contact PI
Yearly Mass Treatment C. Trachomatis: When Can We Stop?$292,642
R01 · FY2008 · EY · contact PI
CORE--BISTATISTICAL/CVRC$290,255
P30 · FY2008 · EY · contact PI
Who drives safely? Visual/cognitive predictors in Elders$1,124,277
R01 · FY2007 · AG · contact PI
Latino Eye Health: A Communication Strategy for Diabetes$610,348
R01 · FY2007 · EY · contact PI
Yearly Mass Treatment C. Trachomatis: When Can We Stop?$415,985
R01 · FY2007 · EY · contact PI
CORE--BISTATISTICAL/CVRC$287,974
P30 · FY2007 · EY · contact PI
Yearly Mass Treatment C. Trachomatis: When Can We Stop?$59,182
R01 · FY2007 · EY · contact PI
Who drives safely? Visual/cognitive predictors in Elders$1,157,855
R01 · FY2006 · AG · contact PI
Latino Eye Health: A Communication Strategy for Diabetes$730,063
R01 · FY2006 · EY · contact PI
Yearly Mass Treatment C. Trachomatis: When Can We Stop?$396,877
R01 · FY2006 · EY · contact PI
CORE--BISTATISTICAL/CVRC$232,834
P30 · FY2006 · EY · contact PI
Cataract: Health Disparity for Older African-Americans$67,889
R03 · FY2006 · AG · contact PI
Who drives safely? Visual/cognitive predictors in Elders$1,185,720
R01 · FY2005 · AG
TRIAL OF ANTIBIOTICS TO REDUCE RECURRENT TRICHIASIS$633,919
U01 · FY2005 · EY
Latino Eye Health: A Communication Strategy for Diabetes$521,148
R01 · FY2005 · EY
CORE--BISTATISTICAL/CVRC$225,744
P30 · FY2005 · EY
Cataract: Health Disparity for Older African-Americans$69,311
R03 · FY2005 · AG
Who drives safely? Visual/cognitive predictors in Elders$1,185,720
R01 · FY2004 · AG
Latino Eye Health: A Communication Strategy for Diabetes$729,683
R01 · FY2004 · EY
TRIAL OF ANTIBIOTICS TO REDUCE RECURRENT TRICHIASIS$715,406
U01 · FY2004 · EY
CORE--BISTATISTICAL/CVRC$224,146
P30 · FY2004 · EY
VISUAL IMPAIRMENT &PHYSICAL DISABILITY IN OLDER PERSONS$707,155
R01 · FY2003 · AG
TRIAL OF ANTIBIOTICS TO REDUCE RECURRENT TRICHIASIS$697,532
U01 · FY2003 · EY
TRIAL OF ANTIBIOTICS TO REDUCE RECURRENT TRICHIASIS$304,657
U01 · FY2003 · EY
AMD AND RISK FACTORS IN A HISPANIC POPULATION$110,560
R01 · FY2003 · EY
TRIAL OF ANTIBIOTICS TO REDUCE RECURRENT TRICHIASIS$835,479
U01 · FY2002 · EY
VISUAL IMPAIRMENT &PHYSICAL DISABILITY IN OLDER PERSONS$750,709
R01 · FY2002 · AG
INTERVENTIONS FOR VISUAL LOSS IN NURSING HOME RESIDENTS$522,982
R01 · FY2002 · AG
AMD AND RISK FACTORS IN A HISPANIC POPULATION$258,655
R01 · FY2002 · EY
CORE--BIOSTATISTICS/CLINICAL VISION RESEARCH CENTER$0
P30 · FY2002 · EY
VISUAL IMPAIRMENT &PHYSICAL DISABILITY IN OLDER PERSONS$713,350
R01 · FY2001 · AG
INTERVENTIONS FOR VISUAL LOSS IN NURSING HOME RESIDENTS$686,336
R01 · FY2001 · AG
CATARACT, UV AND OZONE LOSS: MODELS USING SEE DATA$147,764
R03 · FY2001 · EY
CORE--BIOSTATISTICS/CLINICAL VISION RESEARCH CENTER$0
P30 · FY2001 · EY
INTERVENTIONS FOR VISUAL LOSS IN NURSING HOME RESIDENTS$722,031
R01 · FY2000 · AG
VISUAL IMPAIRMENT &PHYSICAL DISABILITY IN OLDER PERSONS$719,907
R01 · FY2000 · AG
CORE--BIOSTATISTICS/CLINICAL VISION RESEARCH CENTER$106,185
P30 · FY2000 · EY